ATC codes: J01GB06
Multi-drug resistant tuberculous Mycobacterium ICD11 code: ML32.00
Complementary Medicines for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control.
Parenteral > General injections > unspecified: 1 g in vial powder for injection (as sulfate) ; 500 mg in vial powder for injection (as sulfate) ; 100 mg in vial powder for injection (as sulfate)
EML status history
Also recommended for children
The recommendation is for this specific medicine
Patents have expired in most jurisdictions
Read more about patents.
Summary of evidence and Expert Committee recommendations
Additional strengths of amikacin powder for injection were added to the complementary list of the EML and EMLc for treatment of MDR-TB.